Merrimack Pharmaceuticals ($MACK) is currently trading at $11.94, a gain of over+$7.94 (+198.50%). MACK had good news this morning and is running like a train out of control, crushing bears along the way. Back in 2017, Ipsen had gained exclusive commercialization rights for the current and potential future indications of Merrimack’s pancreatic cancer drug Onivyde.
MACK is surging today after Ipsen SA (OTC: IPSEY) announced that the Phase 3 NAPOLI 3 trial of Onivyde plus 5 fluorouracil/leucovorin and oxaliplatin (NALIRIFOX regimen) met its primary endpoint. The combination therapy demonstrated a clinically meaningful and statistically significant improvement in overall survival compared to nab-paclitaxel plus gemcitabine in 770 previously untreated patients with metastatic pancreatic ductal adenocarcinoma (mPDAC).
For the uninitiated, As per the report published by The Brainy Insights, the global pancreatic cancer market is expected to grow from USD 3.43 billion in 2021 to USD 6.93 billion by 2030, at a CAGR of 8.13% during the forecast period 2022-2030 (1). Merrimack is eligible for up to $450 Million in milestone payments for the pancreatic cancer treatment.
Some of other biotech stocks to keep on radar include:
Catalyst Pharmaceuticals (CPRX)
Genmab (GMAB)
Vertex Pharmaceuticals (VRTX)
Harmony Biosciences (HRMY)
Neurocrine Biosciences (NBIX)
For news on Biotech Stocks, please visit Biopharmajournal.com
Source 1: https://www.globenewswire.com/news-release/2022/10/27/2542488/0/en/Pancreatic-Cancer-Market-Size-to-Reach-USD-6-93-Billion-by-2030-Says-The-Brainy-Insights.html
About InvestorBrandMedia.com – The team at InvestorBrandMedia has decades of strategy-driven, extensive media experience in helping navigate our clients through everchanging Digital Landscape. We specialize in a variety of marketing strategies that help promote our client visibility across multiple channels helping them expand the digital footprint in an ever-complex environment. InvestorBrandMedia.com specializes in ticker tagging services. Targeting the right audience is essential. Without effective distribution, a company’s message will fall on deaf ears or play to an empty room. Our growing distribution network consists of a diverse network of finance-focused blogs and websites, producing a robust mix of organic and cultivated interest. Let us help you jumpstart a rich following of qualified leads you can build on. Ticker Tagging is the process wherein your company is included with other sector related NASDAQ, NYSE, AMEX companies showcasing your news within a ticker tagged PR. The ticker tags are distributed to approximately 400 business and financial news portal including Benzinga, Yahoo, Google News, Digital journal and MarketWatch.
